Dave Spaight

Dave Spaight

Private Equity Investor at
Arsenal Capital Management LP
Finance
Consumer Services
Commercial Services

Profile

Mr. Spaight is an Operating Partner of Arsenal for the healthcare team.
Prior to joining Arsenal in 2016, Mr. Spaight served as the Chairman and CEO of WIL Research Laboratories, a leading pre-clinical (“CRO”) acquired by Charles River Laboratories.
Prior to WIL, he served as President of MDS Pharma Services, a global CRO serving all phases of pharmaceutical research and development, from early discovery to late-stage clinical trials and central laboratory support.
Prior to MDS, he held senior leadership positions in Fisher Scientific Products and PerkinElmer.

Dave Spaight active positions

CompaniesPositionStart
Private Equity Investor 2016-07-31

Former positions of Dave Spaight

CompaniesPositionEnd
President 2010-12-30
Private Equity Investor 2005-12-30
See the detail of Dave Spaight's experience

Training of Dave Spaight

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies4

Finance

Consumer Services

Commercial Services

Health Technology